Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Condition: Breast Cancer Intervention: Drug: apatinib+oral etoposide Sponsor: Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials